The logistics behind transporting a COVID-19 vaccine - Cold Chain Summit

The instability of early-stage COVID-19 vaccines will push the limits of supply chain capabilities worldwide, but as more traditional medicines enter the market, distribution will become easier for many logistics companies and regions of the world, a key figure in DHL’s preparations for the blockbuster shipping event said. At least 10 billion doses of coronavirus vaccine will likely be required to immunize 7.8 billion people worldwide, according to some estimates. More than 220 vaccine candidates are under development, including nine in Phase 3 trials that could be approved in the coming weeks and months. Some drug companies are using new technologies to speed up development, but these vaccines contain a high-protein base and need to be stored at ultra-cold temperatures as low as minus 80 degrees Celsius. “In the initial phases it’s quite plausible we’ll see many shipments that are direct to the point of inoculation,” Larry St. Onge, president of life sciences and health care for DHL Customer Solutions, said in a virtual presentation to the FreightWaves Cold Chain Summit Watch Apple Podcast Spotify More FreightWaves Podcasts Learn more about your ad choices. Visit megaphone.fm/adchoices